- Home
- VLY vs KLTOW Comparison
VLY vs KLTOW Comparison
Compare VLY & KLTOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VLY
- KLTOW
- Stock Information
- Founded
- VLY 1927
- KLTOW N/A
- Country
- VLY United States
- KLTOW United States
- Employees
- VLY N/A
- KLTOW 3
- Industry
- VLY Major Banks
- KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VLY Finance
- KLTOW Health Care
- Exchange
- VLY Nasdaq
- KLTOW Nasdaq
- Market Cap
- VLY 5.2B
- KLTOW N/A
- IPO Year
- VLY N/A
- KLTOW 2022
- Fundamental
- Price
- VLY $11.19
- KLTOW $0.15
- Analyst Decision
- VLY Buy
- KLTOW
- Analyst Count
- VLY 15
- KLTOW 0
- Target Price
- VLY $12.80
- KLTOW N/A
- AVG Volume (30 Days)
- VLY 15.0M
- KLTOW N/A
- Earning Date
- VLY 10-23-2025
- KLTOW N/A
- Dividend Yield
- VLY 3.93%
- KLTOW N/A
- EPS Growth
- VLY 40.78
- KLTOW N/A
- EPS
- VLY 0.88
- KLTOW N/A
- Revenue
- VLY $1,704,193,000.00
- KLTOW N/A
- Revenue This Year
- VLY $33.85
- KLTOW N/A
- Revenue Next Year
- VLY $9.50
- KLTOW N/A
- P/E Ratio
- VLY $12.72
- KLTOW N/A
- Revenue Growth
- VLY 8.06
- KLTOW N/A
- 52 Week Low
- VLY $7.48
- KLTOW N/A
- 52 Week High
- VLY $11.28
- KLTOW N/A
- Technical
- Relative Strength Index (RSI)
- VLY 61.50
- KLTOW 45.17
- Support Level
- VLY $9.71
- KLTOW $0.15
- Resistance Level
- VLY $11.28
- KLTOW $0.17
- Average True Range (ATR)
- VLY 0.43
- KLTOW 0.03
- MACD
- VLY 0.08
- KLTOW -0.00
- Stochastic Oscillator
- VLY 94.80
- KLTOW 28.65
About VLY Valley National Bancorp
Valley National Bancorp is a bank holding company that offers a full suite of national and regional banking solutions through various commercial, private banking, retail, insurance, and wealth management financial services products. It provides personalized service and customized solutions to assist its customers with their financial service needs. The group also offers niche financial services, including loan and deposit products for homeowners associations, cannabis-related business banking, and venture banking, which offers nationally. It manages its business operations under operating segments consisting of Consumer Banking; Commercial Banking; and Treasury and Corporate Other. The group generates the majority of its revenue from the Commercial Banking Segment.
About KLTOW Klotho Neurosciences Inc. Warrant
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.